Growth Metrics

Alnylam Pharmaceuticals (ALNY) EPS (Basic) Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -79.34%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 61.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,207.14%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,207.14%
Dec 31, 2025 229.23%
Sep 30, 2025 319.54%
Jun 30, 2025 -292.31%
Mar 31, 2025 73.08%
Dec 31, 2024 40.37%
Sep 30, 2024 -173.73%
Jun 30, 2024 94.12%
Mar 31, 2024 62.86%
Dec 31, 2023 35.12%
Sep 30, 2023 135.54%
Jun 30, 2023 3.49%
Mar 31, 2023 30.00%
Dec 31, 2022 22.22%
Sep 30, 2022 -93.02%
Jun 30, 2022 -42.24%
Mar 31, 2022 -16.96%
Dec 31, 2021 -3.35%
Sep 30, 2021 21.10%
Jun 30, 2021 -3.21%
Mar 31, 2021 -5.56%
Dec 31, 2020 15.38%
Sep 30, 2020 -13.54%
Jun 30, 2020 22.77%
Mar 31, 2020 6.36%
Dec 31, 2019 -18.18%
Sep 30, 2019 20.99%
Jun 30, 2019 -23.93%
Mar 31, 2019 -22.70%
Dec 31, 2018 -41.22%
Sep 30, 2018 -81.34%
Jun 30, 2018 -21.64%
Mar 31, 2018 -12.80%
Dec 31, 2017 -12.12%
Sep 30, 2017 -10.74%
Jun 30, 2017 -27.62%
Mar 31, 2017 -3.31%
Dec 31, 2016 -23.36%
Sep 30, 2016 -32.97%
Jun 30, 2016 -23.53%
Mar 31, 2016 -95.16%
Dec 31, 2015 -282.14%
Sep 30, 2015 -56.90%
Jun 30, 2015 -46.55%
Mar 31, 2015 83.24%
Dec 31, 2014 45.10%
Sep 30, 2014 -20.83%
Jun 30, 2014 -100.00%
Mar 31, 2014 -2,366.67%
Dec 31, 2013 57.50%
Sep 30, 2013 -26.32%
Jun 30, 2013 -16.00%
Mar 31, 2013 40.00%
Dec 31, 2012 -263.64%
Sep 30, 2012 -22.58%
Jun 30, 2012 24.24%
Mar 31, 2012 34.21%
Dec 31, 2011 -94.12%
Sep 30, 2011 -34.78%
Jun 30, 2011 5.71%
Dec 31, 2010 9.16%